Orlistat Market Report 2024 (Global Edition)

Global Orlistat Market Report 2024 Market Size Split by Type (120mg, 60mg), by Application (Weight-reducing Aid, Others), by Distribution Channel (Retailer, Online, Others)

Orlistat Market Report Description

We have various report editions of Orlistat Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Orlistat Market

The competitive landscape of the Orlistat market is characterized by the presence of several pharmaceutical companies and manufacturers competing to gain market share and establish their products as leading choices for obesity management. Key players in the market include major pharmaceutical companies such as GlaxoSmithKline, Roche, Teva Pharmaceuticals, and Mylan, among others.

Orlistat Industry News

In September 2018 Ethicon.inc (US), a part of Johnson & Johnson, launched a new comprehensive surgical solution for bariatric revision surgery designed to help surgeons perform bariatric revision surgery with efficiency, precision and consistency.

(Source: https://www.jnjmedtech.com/en-US/news-events/ethicon-launches-comprehensive-solution-bariatric-revision-surgery)

In October 2022 Eli Lilly and Compan received U.S. Food and Drug Administration's (FDA) fast track or tirzepatide for the treatment of adults with obesity, or overweight with weight-related comorbidities.

(Source:  https://www.biospace.com/article/lilly-s-tirzepatide-shows-strong-weight-loss-efficacy-in-phase-iii-study/#:~:text=Lilly%20is%20)

Top Companies Market Share in Orlistat Industry: (In no particular order of Rank)

• Roche
• GSK group
• Teva
• Sandoz (Novartis)
• STADA-VN J.V.Co. Ltd
• Hexal AG
• National Company for Pharmaceutical Industry
• Lunan Pharmaceutical Group Corporation
• ZEIN pharmaceutical
• HISUN
• Taj Pharmaceuticals Ltd
• Kabir Life Sciences & Research
• DM Pharma
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of Orlistat

Which Region Dominates the Orlistat Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. North America emerges as the dominant region in the Orlistat market due to several key factors. Firstly, North America has a high prevalence of obesity, with a significant portion of the population seeking effective weight management solutions. This substantial demand for obesity treatments drives the adoption of Orlistat medications in the region. Secondly, North America boasts a well-established healthcare infrastructure and robust pharmaceutical industry, facilitating widespread access to Orlistat formulations through healthcare providers and pharmacies.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific emerges as the fastest-growing region in the Orlistat market due to several key factors. Firstly, the region has been experiencing a rapid increase in the prevalence of obesity and related health issues, driven by factors such as urbanization, sedentary lifestyles, and changing dietary habits. As awareness about the health risks associated with obesity grows, there is a rising demand for effective weight management solutions, including Orlistat medications.

The current report Scope analyzes Orlistat Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Orlistat Market

According to Cognitive Market Research, the global Orlistat market size was estimated at USD 3152.2 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1260.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2031.In North America, the Orlistat market exhibits robust growth driven by several factors. Regional analysis reveals a high prevalence of obesity and related health concerns, leading to a substantial demand for weight management solutions like Orlistat. Segmentation analysis indicates a diverse consumer base, including individuals seeking over-the-counter weight loss aids and those prescribed Orlistat by healthcare professionals. In conclusion, North America presents a lucrative opportunity for the Orlistat market, driven by increasing obesity rates, a diverse consumer base, and effective distribution channels.

• According to Cognitive Market Research, the US had a major share in the Orlistat market with a market size of USD 994.83million in 2024 and is projected to grow at a CAGR of 4.1%during the forecast period. The demand is amplified by the nation's increasing obesity rates, a diverse consumer base, and effective distribution channels propel consistent growth. 
• The Canada Orlistat market had a market share of USD 151.31 million in 2024 and is projected to grow at a CAGR of 5.1%during the forecast period. Canada's increasing obesity rates, a diverse consumer base to increased usage of Orlistat.
• The Mexico Orlistat market is projected to witness growth at a CAGR of 4.8%during the forecast period with a market size of USD 114.74million in 2024.

Europe Orlistat Market

According to Cognitive Market Research, the global Orlistat market size was estimated at USD 3152.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 945.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2031. In Europe, the Orlistat market demonstrates a steady trajectory influenced by various factors. Regional analysis indicates a significant prevalence of obesity across Europe, driving demand for weight management solutions like Orlistat. Segmentation analysis reveals a diverse consumer base, including individuals seeking non-prescription weight loss aids and those prescribed Orlistat by healthcare professionals. In conclusion, Europe presents a promising landscape for the Orlistat market, driven by rising obesity rates, a diverse consumer base, and supportive regulatory frameworks. However, market players must navigate challenges such as competition from alternative weight loss solutions and regulatory hurdles.

• The United Kingdom Orlistat market had a market share of USD million in 2024 and is projected to grow at a CAGR of 5.4%during the forecast period. In the UK, Orlistat sales witness an upswing due to the nation's rising obesity rates, a diverse consumer base.
• The France Orlistat market is projected to witness growth at a CAGR of 3.8%during the forecast period with a market size of USD 87.00million in 2024.
• According to Cognitive Market Research, the Germany Orlistat market size was valued at USD 187.24 million in 2024 and is projected to grow at a CAGR of 4.8%during the forecast period. In Germany, Orlistat sales surge due to the nation's prevalence of obesity. 
• The Italy Orlistat market is projected to witness growth at a CAGR of 4.0% during the forecast period with a market size of USD 81.33million in 2024.
• The Russia Orlistat market is projected to witness growth at a CAGR of 3.6%during the forecast period with a market size of USD 146.58million in 2024.
• The Spain Orlistat market is projected to witness growth at a CAGR of 3.7%during the forecast period with a market size of USD 77.54million in 2024.
• The Luxembourg Orlistat market is projected to witness growth at a CAGR of 4.7% during the forecast period with a market size of USD 29.32million in 2024.
• The Portugal Orlistat market is projected to witness growth at a CAGR of 4.4%during the forecast period with a market size of USD 19.86million in 2024.
• The Greece Orlistat market is projected to witness growth at a CAGR of 4.9%during the forecast period with a market size of USD 11.35million in 2024.
• Rest of Europe Orlistat market is projected to witness growth at a CAGR of 3.3%during the forecast period with a market size of USD 146.58million in 2024.

 

Asia Pacific Orlistat Market

According to Cognitive Market Research, the global Orlistat market size was estimated at USD 3152.2 Million out of which Asia Pacific held the market ofaround23% of the global revenue with a market size of USD 725.01 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.1%from 2024 to 2031.In the Asia Pacific region, the Orlistat market exhibits a dynamic landscape shaped by several factors. Regional analysis suggests a rising prevalence of obesity and overweight population, particularly in countries undergoing rapid urbanization and lifestyle changes. Segmentation analysis reveals a diverse consumer base, including individuals seeking pharmaceutical interventions for weight management and those inclined towards natural or alternative remedies. In conclusion, the Orlistat market in the Asia Pacific region holds immense potential for growth, fueled by rising obesity rates, shifting consumer preferences towards healthier lifestyles, and supportive regulatory frameworks.

• According to Cognitive Market Research, the China Orlistat market size was valued at USD 326.25million in 2024 and is projected to grow at a CAGR of 7.6%during the forecast period. Orlistat sales surge in China due to the nation's rising obesity rates, shifting consumer preferences towards healthier lifestyles.
• The JapanOrlistat market is projected to witness growth at a CAGR of 6.6%during the forecast period with a market size of USD 100.05million in 2024.
• The IndiaOrlistat market had a market share of USD 87.00million in 2024 and is projected to grow at a CAGR of 9.9%during the forecast period. The demand is augmented by India's increasing focus on precision medicine and its role as a key player in the global pharmaceutical industry.
• The South KoreaOrlistat market is projected to witness growth at a CAGR of 7.2%during the forecast period with a market size of USD 72.50million in 2024.
• The AustraliaOrlistat market is projected to witness growth at a CAGR of 7.8%during the forecast period with a market size of USD 37.70million in 2024.
• The South East AsiaOrlistat market is projected to witness growth at a CAGR of 9.1%during the forecast period with a market size of USD 50.03 million in 2024.
• The Rest of Asia PacificOrlistat market is projected to witness growth at a CAGR of 7.9%during the forecast period with a market size of USD 51.48million in 2024.

 

South America Orlistat Market

According to Cognitive Market Research, the global Orlistat market size was estimated at USD 3152.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 157.61 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.In Latin America, the Orlistat market reflects a nuanced landscape influenced by various regional factors. Regional analysis indicates a rising prevalence of obesity and related health issues across countries in the region, driven by changing lifestyles, urbanization, and dietary habits. Segmentation analysis reveals a diverse consumer base, including individuals seeking weight management solutions through pharmaceutical interventions and those exploring alternative wellness practices. In conclusion, the Orlistat market in Latin America holds promising prospects for growth, driven by rising obesity rates and a growing emphasis on preventive healthcare. However, challenges such as affordability, cultural perceptions, and regulatory constraints require careful consideration.

• According to Cognitive Market Research, the Brazil Orlistat market size was valued at USD 67.46million in 2024 and is projected to grow at a CAGR of 6.1%during the forecast period. Orlistat sales flourish in Brazil due to the nation's thriving pharmaceutical industry and increasing investments in healthcare infrastructure.
• The Argentina Orlistat market had a market share of USD 26.48million in 2024 and is projected to grow at a CAGR of 6.4%during the forecast period. The demand is augmented by Argentina's rising obesity rates, shifting consumer preferences towards healthier lifestyles.
• The Colombia Orlistat market is projected to witness growth at a CAGR of 5.3%during the forecast period with a market size of USD 14.03 million in 2024.
• The Peru Orlistat market is projected to witness growth at a CAGR of 5.7%during the forecast period with a market size of USD 12.92million in 2024.
• The Chile Orlistat market is projected to witness growth at a CAGR of 5.8%during the forecast period with a market size of USD 11.35million in 2024.
• The Rest of Latin America Orlistat market is projected to witness growth at a CAGR of 4.6% during the forecast period with a market size of USD 25.38 million in 2024.

 

Middle East and Africa Orlistat Market

According to Cognitive Market Research, the global Orlistat market size was estimated at USD 3152.2 Million out of which Middle East and Africa held the major market ofaround 2% of the global revenue with a market size of USD 63.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.8%from 2024 to 2031.In the Middle East and Africa (MEA) region, the Orlistat market exhibits a unique set of characteristics influenced by socioeconomic factors, cultural preferences, and healthcare infrastructure. Regional analysis suggests a growing prevalence of obesity and related health conditions, driven by urbanization, sedentary lifestyles, and changing dietary habits. Segmentation analysis reveals diverse consumer demographics, including individuals seeking weight management solutions for health reasons and those interested in cosmetic enhancements. In conclusion, the Orlistat market in the Middle East and Africa region holds significant potential for expansion, driven by rising obesity rates and increasing awareness of health issues.

• According to Cognitive Market Research, the GCC Countries Orlistat market size was valued at USD 26.98million in 2024 and is projected to grow at a CAGR of 6.6%during the forecast period. Orlistat sales flourish in the GCC Countries due to the region's rising obesity rates and increasing awareness of health issues.
• The Egypt Orlistat market is projected to witness growth at a CAGR of 6.1%during the forecast period with a market size of USD 6.62million in 2024.
• The South Africa Orlistat market is projected to witness growth at a CAGR of 6.8%during the forecast period with a market size of USD 9.96million in 2024.Orlistat sales flourish in the South Africa due to the region's by urbanization, sedentary lifestyles, and changing dietary habits.
• The Turkey Orlistat market is projected to witness growth at a CAGR of 5.3%during the forecast period with a market size of USD 5.42million in 2024.
• The Nigeria Orlistat market is projected to witness growth at a CAGR of 4.9%during the forecast period with a market size of USD 6.62million in 2024.
• The Rest of MEA Orlistat market is projected to witness growth at a CAGR of 4.8%during the forecast period with a market size of USD 7.44million in 2024.

Orlistat Market Analysis

Orlistat Type Segment Analysis

According to Cognitive Market Research, the dominating category is the 120mg dosage variant. This higher dosage strength is often prescribed for individuals with severe obesity or those who have struggled to achieve weight loss with lower doses. Physicians may prefer prescribing the 120mg dosage to patients with a higher body mass index (BMI) or those with obesity-related health complications due to its enhanced efficacy in inhibiting fat absorption. Additionally, patients who have previously tried the 60mg dosage without success may be prescribed the 120mg variant for better outcomes. Moreover, the 120mg dosage is often perceived as more effective by consumers, leading to higher demand and sales volume compared to the 60mg variant.

The fastest-growing category in the Orlistat market is the 60mg dosage variant. This lower dosage strength is typically recommended for individuals with moderate obesity or those who are at risk of developing obesity-related health issues. The 60mg dosage is preferred for patients who are starting their weight loss journey or for those who may experience milder side effects. Furthermore, the 60mg dosage may be prescribed for long-term weight management in individuals who have achieved initial weight loss goals. The increasing trend towards preventive healthcare and early intervention has led to a growing demand for the 60mg dosage, driving its rapid growth in the Orlistat market.

• 120mg
• 60mg

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Orlistat Industry. Request a Free Sample PDF!

Orlistat Application Segment Analysis

According to Cognitive Market Research, the dominating category is weight-reducing aid applications. Orlistat is primarily used as a weight loss medication to help individuals achieve and maintain a healthy body weight. It works by blocking the absorption of dietary fat in the intestines, thereby reducing calorie intake and promoting weight loss. Given the rising global prevalence of obesity and overweight conditions, there is a growing demand for effective weight management solutions, driving the dominance of weight-reducing aid applications in the Orlistat market. Additionally, healthcare professionals often prescribe Orlistat as part of comprehensive weight loss programs, further contributing to its prominence in this application category.

The fastest-growing category in the Orlistat market is other applications. While weight reduction remains the primary indication for Orlistat use, researchers and healthcare providers are exploring its potential in addressing various other health conditions. Orlistat's mechanism of action, which involves inhibiting fat absorption in the gastrointestinal tract, may have therapeutic benefits beyond weight management. Studies have suggested its efficacy in managing conditions such as non-alcoholic fatty liver disease (NAFLD), polycystic ovary syndrome (PCOS), and metabolic syndrome. As research continues to uncover new therapeutic avenues for Orlistat, the demand for its use in these alternative applications is witnessing rapid growth, making it the fastest-growing category in the Orlistat market.

• Weight-reducing Aid
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Orlistat Distribution Channel Segment Analysis

According to Cognitive Market Research, the dominating distribution channel is through retailers. This includes pharmacies, drugstores, and supermarkets where Orlistat products are readily available over the counter. Retailers play a crucial role in reaching a wide consumer base, as they are easily accessible and trusted sources for purchasing healthcare products. Consumers often prefer to purchase Orlistat from retailers due to the convenience of obtaining the product during their routine shopping trips. Moreover, retailers may offer discounts, promotional offers, and personalized recommendations to attract customers, further strengthening their dominance in the distribution of Orlistat products.

The fastest-growing distribution channel in the Orlistat market is through online platforms. With the increasing prevalence of e-commerce and the growing consumer preference for online shopping, the demand for Orlistat through online channels has surged significantly. Online platforms offer convenience, privacy, and a wide range of product options to consumers, making it easier for them to access Orlistat from the comfort of their homes. Additionally, the COVID-19 pandemic has accelerated the shift towards online shopping, as consumers prioritize safety and social distancing measures.

• Retailer
• Online
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion